image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Synergy Healthcare -

January 2008

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SYR
  • Price:
  • 769p
Synergy produced strong interim results, with revenues (includingIsotron) rising 52% to £102m, while underlying revenue growth wasnearly 17%. Operating profit increased 115% to £15.3m, while eps rose27% to 15.5p, which was slightly ahead of forecasts. The forward orderbook has also increased by £65m to £765m. Synergy’s patient care division (linen management) enjoyed a 19%jump in revenues to nearly £62m, driven by a strong performance ininfection control and good progress with new products such as AirCleanse and its new MRSA screening service. As NHS outsourcing is stillaccelerating, Synergy has won several more contracts both in the UK andHolland. Meanwhile, the surgical division, which is involved in thesterilisati ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X